Alievio

Alevio has developed a device for treating glaucoma to target intraocular pressure (IOP). The company has developed a small noninvasive device used to remove the intraocular pressure by draining the aqueous humor and enables the physicians to maintain the IOP by adjusting the pressure. The company claims that the outlet tube is as soft as a contact lens. Founded in 2010, headquartered in Durham, United States. The company has raised $12.2M in funding at the series a stage. The team comprises 3 ( The company operates in Life Sciences > Ophthalmology, High Tech > Wearable Technology, Internet of Things - Industry Applications > Wearable Technology. Its business models include Wearable Technology > Health and Wellness Devices > Eyecare, Ophthalmology > Medical Devices > Therapy > Glaucoma > Shunt. Founded in 2010. Headquartered in United States, Durham. The company has raised funding at the Series A stage. Backed by investors including America’s Seed Fund, NIH, Charlotte Angel Fund, Triangle Angel Partners, VCapital, InFocus Capital Partners, Pilot Mountain Ventures, Triangle Venture Alliance, First Flight Venture Center, IMAF Sandhills.